Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • Dow

    39,760.08
    +477.75 (+1.22%)
     
  • Nasdaq

    16,399.52
    +83.82 (+0.51%)
     
  • Bitcoin USD

    70,674.77
    +604.62 (+0.86%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,955.85
    +23.87 (+0.30%)
     
  • Gold

    2,232.90
    +20.20 (+0.91%)
     
  • Crude Oil

    82.20
    +0.85 (+1.04%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

SHAREHOLDER ALERT: WeissLaw LLP Reminds ETFC, TCO, TERP, and TTPH Shareholders About Its Ongoing Investigations

NEW YORK, May 05, 2020 (GLOBE NEWSWIRE) --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

E*TRADE Financial Corporation (ETFC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of E*TRADE Financial Corporation (ETFC) in connection with the proposed acquisition of the company by Morgan Stanley (“MS”). Under the terms of the acquisition agreement, ETFC shareholders will receive 1.0432 shares of MS for each ETFC share that they own, representing implied per-share consideration of only $39.74 based on MS’s May 4, 2020 closing price of $38.09. If you own ETFC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/e-trade-financial-corporation/

ADVERTISEMENT

Taubman Centers, Inc. (TCO)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Taubman Centers, Inc. (TCO) in connection with the proposed acquisition of the company by rival shopping mall firm, Simon Property Group. Under the terms of the acquisition agreement, TCO shareholders will receive $52.50 in cash for each share of TCO common stock that they own. If you own TCO shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/taubman-centers-inc/

TerraForm Power, Inc. (TERP)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of TerraForm Power, Inc. (TERP) in connection with the proposed acquisition of the company by Brookfield Renewable Partners (“BEP”). BEP and its affiliates already control 62% of TERP shares and are attempting to acquire the remaining 38% of TERP shares they do not currently control. Under the terms of the acquisition agreement, TERP shareholders will receive 0.36 BEP shares for each share of TERP they own, which represents implied per-share merger consideration of $16.07 based on BEP’s May 4, 2020 closing price of $44.64. If you own TERP shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/terraform-power-inc-investigation/

Tetraphase Pharmaceuticals, Inc. (TTPH)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Tetraphase Pharmaceuticals, Inc. (TTPH) in connection with the proposed acquisition of the company by AcelRX Pharmaceuticals, Inc. (“ACRX”). Under the terms of the acquisition agreement, shareholders will receive (i) 0.6303 shares of ACRX common stock for each share of TTPH they own, representing implied per-share merger consideration of $0.95 per share based on ACRX’s May 4, 2020 closing price of $1.51, and (ii) one contingent value right (“CVR”) entitling CVR holders to receive aggregate payments of up to $12.5 million for the achievement of future XERAVA net sales milestones starting in 2021. If you own TTPH shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/tetraphase-pharmaceuticals-inc/